Chlorhexidine & Pneumonia in Nursing Home Residents
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00841074|
Recruitment Status : Completed
First Posted : February 11, 2009
Last Update Posted : April 14, 2017
|Condition or disease||Intervention/treatment||Phase|
|Pneumonia Respiratory Infection||Drug: chlorhexidine Drug: Placebo mouthwash||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||75 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||Effect of Topical Oral Chlorhexidine in Reducing Pneumonia in Nursing Home Residents|
|Study Start Date :||January 2006|
|Actual Primary Completion Date :||July 2011|
|Actual Study Completion Date :||July 2011|
0.12% chlorhexidine mouthwash spray, ~1.3 ml, twice a day.
Other Name: Peridex
Placebo Comparator: 2
Drug: Placebo mouthwash
Placebo mouthwash spray application of ~1.3 ml twice a day.
Other Name: Peridex mouthwash without chlorhexidine.
- Pneumonia [ Time Frame: 12 months ]
- Respiratory pathogens [ Time Frame: 12 months ]
- Plaque and Gingival Indices [ Time Frame: 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00841074
|United States, Kentucky|
|University of Louisville|
|Louisville, Kentucky, United States, 40202|
|Principal Investigator:||Catherine J Binkley, DDS, PhD||University of Louisville|